Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates.
Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium.
For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register.
For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.

Patent details

1417232 Title: ANTICORPS MONOCLONAUX HUMAINS DIRIGES CONTRE LE RECEPTEUR DE FACTEUR DE CROISSANCE EPIDERMIQUE (EGFR)

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic information

Application number:
027443209
WO application number:
US2002018748
Type:
European patent granted for BE
Status:
Deemed Void
Publication number:
1417232
WO publication number:
WO2002100348
1rst applicant's nationality:
Translation language:
EPO publication language:
English
SPC number:

Dates

Filing date:
13/06/2002
Grant date:
03/12/2014
EP publication date:
12/05/2004
WO publication date:
19/12/2002
Claims translation received date:
Translation received date (EP publication B1):
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
03/12/2014
EP B1 publication date:
03/12/2014
EP B2 publication date:
EP B3 publication date:
Lapsed date:
Expiration date (if granted and all annual fees paid):
13/06/2022

Applicant

Name:
Genmab A/S
Legal Form:
From:
03/12/2014
Address:
Bredgade 34 E, 1260 Copenhagen K, Denmark (DK)
To:

Inventor

1

Name:
VAN DE WINKEL, Jan
Legal Form:
Address:
3707 CK Zeist, Netherlands (NL)

2

Name:
VAN DIJK, Marcus A.
Legal Form:
Address:
3722 ZH Bilthoven, Netherlands (NL)

3

Name:
GERRITSEN, Arnout F.
Legal Form:
Address:
3981 TB Bunnik, Netherlands (NL)

4

Name:
HALK, Edward
Legal Form:
Address:
Sunnyvale, CA 94087, United States (US)

Priority

Priority patent number:
298172
Priority date:
13/06/2001
Priority country:
United States (US)

Classification

IPC or IDT classification:
C07K 16/28; G01N 33/563; C12N 15/00; A61K 39/395; C12P 21/00; A61P 35/00;

Publication

European Patent Bulletin

Issue number:
201449
Publication date:
03/12/2014
Description:
Grant (B1)

Annual fee

Annual fee(s) Due Date:
31/12/2015
Annual fee number:
14
Annual fee amount:
290 Euro
Penalty fee amount:
210 Euro
Expected payer:
Last annual fee payment date:
Last annual fee paid number:
Payer:
Filing date Document type Publication Type Document Description Number of pages File Type